Shares of Cardinal Health, Inc. (NYSE:CAH – Get Free Report) have been given an average rating of “Moderate Buy” by the sixteen brokerages that are covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $209.00.
CAH has been the topic of a number of research analyst reports. TD Cowen boosted their price target on Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 3rd. Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Barclays began coverage on Cardinal Health in a report on Monday, December 8th. They set an “overweight” rating and a $243.00 target price for the company. Argus lifted their price target on shares of Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a report on Tuesday, November 4th. Finally, Mizuho upped their price objective on shares of Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a report on Monday, November 3rd.
View Our Latest Analysis on CAH
Institutional Trading of Cardinal Health
Cardinal Health Stock Performance
Shares of Cardinal Health stock opened at $208.25 on Wednesday. Cardinal Health has a 52-week low of $119.11 and a 52-week high of $214.93. The company’s 50 day moving average price is $202.72 and its 200-day moving average price is $172.39. The stock has a market capitalization of $49.48 billion, a price-to-earnings ratio of 31.41, a P/E/G ratio of 1.50 and a beta of 0.65.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The company had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The firm’s revenue was up 22.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities research analysts forecast that Cardinal Health will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio is presently 30.77%.
About Cardinal Health
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Further Reading
- Five stocks we like better than Cardinal Health
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- This stock gets a 94 out of 100
- BNZI: BNZI Surges Ahead as AI Marketing Fuels Record Revenue
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
